DONATE

IBEC Seminar

Views Navigation

Event Views Navigation

Today
  • IBEC Seminar: Johanna Ivaska

    IBEC, floor 11, Tower I Baldiri Reixac 4-8, 08028 Barcelona, Spain

    Mechanosensitive regulation of cancer and pluripotency

  • IBEC Seminar: Johanna Ivaska

    IBEC, floor 11, Tower I Baldiri Reixac 4-8, 08028 Barcelona, Spain

    Mechanosensitive regulation of cancer and pluripotency

  • IBEC Seminar: Carlo A. Bortolotti

    IBEC, floor 11, Tower I Baldiri Reixac 4-8, 08028 Barcelona, Spain

    Monitoring biorecognition with organic bioelectronic transistors

  • IBEC Seminar: Carlo A. Bortolotti

    IBEC, floor 11, Tower I Baldiri Reixac 4-8, 08028 Barcelona, Spain

    Monitoring biorecognition with organic bioelectronic transistors

  • IBEC Seminar: Aurélien Bancaud

    IBEC, floor 11, Tower I Baldiri Reixac 4-8, 08028 Barcelona, Spain

    µLAS technology for DNA processing: setting up elementary functions (concentration, separation, purification, identification) and application in oncology and targeted sequencing

  • IBEC Seminar: Aurélien Bancaud

    IBEC, floor 11, Tower I Baldiri Reixac 4-8, 08028 Barcelona, Spain

    µLAS technology for DNA processing: setting up elementary functions (concentration, separation, purification, identification) and application in oncology and targeted sequencing

  • IBEC Seminar: Fernando López-Gallego

    IBEC, floor 11, Tower I Baldiri Reixac 4-8, 08028 Barcelona, Spain

    Immobilization of multi-enzyme systems; an avenue to fabricate self-sufficient heterogeneous biocatalysts

  • IBEC Seminar: Fernando López-Gallego

    IBEC, floor 11, Tower I Baldiri Reixac 4-8, 08028 Barcelona, Spain

    Immobilization of multi-enzyme systems; an avenue to fabricate self-sufficient heterogeneous biocatalysts

  • IBEC Seminar: Joan Seoane

    IBEC, floor 11, Tower I Baldiri Reixac 4-8, 08028 Barcelona, Spain

    Intratumor heterogeneity in brain cancer

  • IBEC Seminar: Joan Seoane

    IBEC, floor 11, Tower I Baldiri Reixac 4-8, 08028 Barcelona, Spain

    Intratumor heterogeneity in brain cancer